Pre‐symptomatic risdiplam treatment for spinal muscular atrophy initiated at 12 days post‐birth: 14‐month safety and developmental outcomes

Documenti analoghi

• Spotlight on eltrombopag concentration in pediatric immune thrombocytopenia: A single‐center observational study in China
  di: Shuyue Dong, et al.
  Pubblicazione: (2024)
• Effectiveness and safety of perampanel for pediatric patients with epilepsy: A real‐world study from China
  di: Xiaohui Wang, et al.
  Pubblicazione: (2025)
• Comparative analysis of formulae for umbilical venous catheterization depth based on birth weight
  di: Jingjie Luo, et al.
  Pubblicazione: (2024)
• Academic burnout and internet gaming disorder in Chinese adolescents: The chain mediating roles of depressive symptoms and negative attentional bias
  di: Yalei Li, et al.
  Pubblicazione: (2026)
• Low‐dose immune tolerance induction for severe hemophilia A inhibitor patients: Immunosuppressants are generally not necessary for inhibitor‐titer below 200 BU/mL
  di: Zhengping Li, et al.
  Pubblicazione: (2024)